Drug Trial Radar · NCT02217709
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Sep 8, 2014
Primary completion
Jun 29, 2020
Study completion Jun 29, 2020
Sponsor
- Lead sponsor
- University of Southern CaliforniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Aug 15, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II trial studies phenelzine sulfate in treating patients with prostate cancer that has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of antidepressant that works by decreasing the amount of a protein called monoamine oxidase (MAO). MAO drugs may have an anticancer effect in prostate cancer.
Conditions
- Adenocarcinoma of the Prostate
- Recurrent Prostate Cancer
- Stage I Prostate Cancer
- Stage IIA Prostate Cancer
- Stage IIB Prostate Cancer
- Stage III Prostate Cancer
Interventions
phenelzine sulfateDrug
Given by mouth
laboratory biomarker analysisOther
Correlative studies
questionnaire administrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients With PSA Decline of >= 50% From Baseline Following at Least 12 Weeks of Treatment With Phenelzine SulfateTime frame: Baseline to up to 12 months
- Number of Patients With PSA Decline of >= 30% From Baseline Following at Least 12 Weeks of Treatment With Phenelzine SulfateTime frame: Baseline to up to 12 months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
USC Norris Westside Cancer Center
Beverly Hills, California
Los Angeles County-USC Medical Center
Los Angeles, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
Keck Medical Center of USC Pasadena
Pasadena, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.